378 related articles for article (PubMed ID: 33091700)
1. COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy.
Daughety MM; Morgan A; Frost E; Kao C; Hwang J; Tobin R; Patel B; Fuller M; Welsby I; Ortel TL
Thromb Res; 2020 Dec; 196():483-485. PubMed ID: 33091700
[TBL] [Abstract][Full Text] [Related]
2. The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin.
Prandoni P; Cattelan AM; Carrozzi L; Leone L; Filippi L; De Gaudenzi E; Villalta S; Pesavento R;
Thromb Res; 2020 Dec; 196():395-397. PubMed ID: 33007739
[No Abstract] [Full Text] [Related]
3. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.
Tritschler T; Mathieu ME; Skeith L; Rodger M; Middeldorp S; Brighton T; Sandset PM; Kahn SR; Angus DC; Blondon M; Bonten MJ; Cattaneo M; Cushman M; Derde LPG; DeSancho MT; Diehl JL; Goligher E; Jilma B; Jüni P; Lawler PR; Marietta M; Marshall JC; McArthur C; Miranda CH; Mirault T; Morici N; Perepu U; Schörgenhofer C; Sholzberg M; Spyropoulos AC; Webb SA; Zarychanski R; Zuily S; Le Gal G;
J Thromb Haemost; 2020 Nov; 18(11):2958-2967. PubMed ID: 32888372
[TBL] [Abstract][Full Text] [Related]
4. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Bikdeli B; Talasaz AH; Rashidi F; Sharif-Kashani B; Farrokhpour M; Bakhshandeh H; Sezavar H; Dabbagh A; Beigmohammadi MT; Payandemehr P; Yadollahzadeh M; Riahi T; Khalili H; Jamalkhani S; Rezaeifar P; Abedini A; Lookzadeh S; Shahmirzaei S; Tahamtan O; Matin S; Amin A; Parhizgar SE; Jimenez D; Gupta A; Madhavan MV; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Mohebbi B; Piazza G; Kirtane AJ; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
Thromb Res; 2020 Dec; 196():382-394. PubMed ID: 32992075
[TBL] [Abstract][Full Text] [Related]
5. The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: The Padua province experience.
Pesavento R; Ceccato D; Pasquetto G; Monticelli J; Leone L; Frigo A; Gorgi D; Postal A; Marchese GM; Cipriani A; Saller A; Sarais C; Criveller P; Gemelli M; Capone F; Fioretto P; Pagano C; Rossato M; Avogaro A; Simioni P; Prandoni P; Vettor R
J Thromb Haemost; 2020 Oct; 18(10):2629-2635. PubMed ID: 32692874
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
Parks AL; Auerbach AD; Schnipper JL; Anstey JE; Sterken DG; Hecht TEH; Fang MC;
Thromb Res; 2020 Dec; 196():355-358. PubMed ID: 32977136
[TBL] [Abstract][Full Text] [Related]
7. Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study.
Stessel B; Vanvuchelen C; Bruckers L; Geebelen L; Callebaut I; Vandenbrande J; Pellens B; Van Tornout M; Ory JP; van Halem K; Messiaen P; Herbots L; Ramaekers D; Dubois J
Thromb Res; 2020 Oct; 194():209-215. PubMed ID: 32788120
[TBL] [Abstract][Full Text] [Related]
8. Thromboprophylaxis strategies to improve the prognosis of COVID-19.
Bertoletti L; Bikdeli B; Zuily S; Blondon M; Mismetti P
Vascul Pharmacol; 2021 Aug; 139():106883. PubMed ID: 34091065
[TBL] [Abstract][Full Text] [Related]
9. Stroke and Thromboprophylaxis in the Era of COVID-19.
Ma A; Kase CS; Shoamanesh A; Abdalkader M; Pikula A; Sathya A; Catanese L; Ellis AT; Nguyen TN
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105392. PubMed ID: 33130478
[No Abstract] [Full Text] [Related]
10. Assessing the risk of recurrent venous thromboembolism--a practical approach.
Fahrni J; Husmann M; Gretener SB; Keo HH
Vasc Health Risk Manag; 2015; 11():451-9. PubMed ID: 26316770
[TBL] [Abstract][Full Text] [Related]
11. Major bleeding complications in critically ill patients with COVID-19 pneumonia.
Godier A; Clausse D; Meslin S; Bazine M; Lang E; Huche F; Cholley B; Hamada SR
J Thromb Thrombolysis; 2021 Jul; 52(1):18-21. PubMed ID: 33646501
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis.
Patell R; Chiasakul T; Bauer E; Zwicker JI
Thromb Haemost; 2021 Jan; 121(1):76-85. PubMed ID: 33378787
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding.
Intagliata NM; Henry ZH; Shah N; Lisman T; Caldwell SH; Northup PG
Liver Int; 2014 Jan; 34(1):26-32. PubMed ID: 23758818
[TBL] [Abstract][Full Text] [Related]
15. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
[TBL] [Abstract][Full Text] [Related]
16. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
[TBL] [Abstract][Full Text] [Related]
17. Immunobullous diseases, prothrombotic state, and COVID-19: Role of prophylactic anticoagulation in bullous pemphigoid and pemphigus.
Anuragi RP; Kansal NK
Dermatol Ther; 2020 Nov; 33(6):e14361. PubMed ID: 33002264
[No Abstract] [Full Text] [Related]
18. Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications.
Kollias A; Kyriakoulis KG; Stergiou GS; Syrigos K
Br J Haematol; 2020 Aug; 190(4):529-532. PubMed ID: 32621757
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
; ; ; Lawler PR; Goligher EC; Berger JS; Neal MD; McVerry BJ; Nicolau JC; Gong MN; Carrier M; Rosenson RS; Reynolds HR; Turgeon AF; Escobedo J; Huang DT; Bradbury CA; Houston BL; Kornblith LZ; Kumar A; Kahn SR; Cushman M; McQuilten Z; Slutsky AS; Kim KS; Gordon AC; Kirwan BA; Brooks MM; Higgins AM; Lewis RJ; Lorenzi E; Berry SM; Berry LR; Aday AW; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Costantini TW; de Brouwer S; Derde LPG; Detry MA; Duggal A; Džavík V; Effron MB; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Galanaud JP; Galen BT; Gandotra S; García-Madrona S; Girard TD; Godoy LC; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Hamburg NM; Haniffa R; Hanna G; Hanna N; Hegde SM; Hendrickson CM; Hite RD; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Hudock K; Hunt BJ; Husain M; Hyzy RC; Iyer VN; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski AL; King AJ; Knudson MM; Kornblith AE; Krishnan V; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Lima FG; Linstrum K; Litton E; Lopez-Sendon J; Lopez-Sendon Moreno JL; Lother SA; Malhotra S; Marcos M; Saud Marinez A; Marshall JC; Marten N; Matthay MA; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Moore SC; Morillo Guerrero R; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nunez-Garcia B; Pandey A; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pérez González YS; Pompilio M; Prekker ME; Quigley JG; Rost NS; Rowan K; Santos FO; Santos M; Olombrada Santos M; Satterwhite L; Saunders CT; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Shankar-Hari M; Sheehan JP; Singhal AB; Solvason D; Stanworth SJ; Tritschler T; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Wells BJ; Widmer RJ; Wilson JG; Yuriditsky E; Zampieri FG; Angus DC; McArthur CJ; Webb SA; Farkouh ME; Hochman JS; Zarychanski R
N Engl J Med; 2021 Aug; 385(9):790-802. PubMed ID: 34351721
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19.
Farrar JE; Trujillo TC; Mueller SW; Beltran L; Nguyen C; Hassell K; Kiser TH
J Thromb Thrombolysis; 2022 Feb; 53(2):446-453. PubMed ID: 34410561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
